Lipid News

Transport of O-palmitoleated Wnts: Where does the lipid go?

Rie Nygaard Filippo Mancia
By Rie Nygaard and Filippo Mancia
Feb. 16, 2021

Wnts are evolutionarily conserved ligands that signal at short range to regulate morphogenesis, cell fate and stem cell renewal. The first and essential step in Wnts' secretion is their O-palmitoleation by the enzyme porcupine, or PORCN. This lipid modification is unique to Wnts and crucial for limiting their diffusion, restricting Wnt signaling to short range.

Lipid-news-445x561.jpg
Rie Nygaard & Filippo Mancia
The structure of human O-palmitoleated WNT8A (green) in complex with its dedicated carrier WLS (blue). The O-palmitoleate is shown as yellow spheres, and the main structural elements are labeled.

Modification of Wnts has been shown to be essential to their signaling capabilities. After their O-palmitoleation in the endoplasmic reticulum, or ER, Wnts are loaded onto their dedicated transporter Wntless, or WLS, an integral membrane protein with a small soluble domain in the ER lumen. O-palmitoleated Wnts associated with WLS then travel to the plasma membrane, where they are transferred to receptors, such as Frizzled, on the membranes of target cells, in turn triggering the activation of signaling pathways. Structures of Wnt in complex with the cysteine-rich domain, or CRD, of Frizzled have shown how the lipid modification of Wnt is central to binding, with the O-palmitoleate buried deep in a hydrophobic groove of the CRD.

Questions remained about Wnts' transfer from the ER to target cells and the role of the O-palmitoleate: How does the transfer of the O-palmitoleated Wnt from PORCN to WLS occur? Where does the O-palmitoleate reside when Wnts are in complex with WLS, within the protein or in the membrane? How are Wnts released from WLS, and how do they travel with their water-insoluble cargo to neighboring cells?

We recently reported the structure of human O-palmitoleated WNT8A in complex with WLS, determined by single-particle cryo-electron microscopy to 3.2 Å resolution. The structure shows that the WLS membrane domain has close structural homology to G protein–coupled receptors, or GPCRs, with the addition of a transmembrane helix connecting the N-terminus to its luminal domain.

Based on the structures of Wnt bound to the CRD domain of Frizzled, we expected that the O-palmitoleate would be inserted into a hydrophobic binding site within the luminal domain of WLS. Instead, the Wnt hairpin carrying the lipid as a covalent attachment inserts deeply into a conserved hydrophobic cavity in the GPCR-like domain with the O-palmitoleate protruding between two transmembrane helices into the lipid bilayer.

We observed an extensive binding surface between Wnt and WLS, consistent with the known tight interaction between the two, while the energetically favorable environment of the membrane sheltered the hydrophobic cargo. A large opening to the bilayer within the membrane domain of WLS might be the route for shuttling the O-palmitoleate from PORCN to WLS, maintaining the lipid within the bilayer during the transfer and possibly involving a direct interaction between the enzyme and the carrier.

Comparing the structure of Wnt in complex with WLS to the structures of Wnt bound to the CRD domain of Frizzled, we observed a large conformational change on a separate Wnt hairpin, which may be important for its one-way transfer to receiving cells. For this transfer to occur, the O-palmitoleate must be extracted from the lipid bilayer and transferred to the CRD domain of Frizzled.

It's unclear if and when this involves other proteins and whether the transfer occurs in cis (the same) or trans (the opposite) membranes.

This work provides molecular-level insights into a central mechanism in animal body plan development and stem cell biology. We believe it opens up a new direction to explore membrane protein–lipid interactions.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Rie Nygaard
Rie Nygaard

Rie Nygaard is an associate research scientist in Filippo Mancia’s lab in the department of physiology and cellular biophysics at Columbia University Irving Medical Center.

Filippo Mancia
Filippo Mancia

Filippo Mancia is an associate professor and co-director of graduate education in the department of physiology and cellular biophysics at Columbia University Irving Medical Center.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Bacteriophage protein could make queso fresco safer
Journal News

Bacteriophage protein could make queso fresco safer

Dec. 18, 2025

Researchers characterized the structure and function of PlyP100, a bacteriophage protein that shows promise as a food-safe antimicrobial for preventing Listeria monocytogenes growth in fresh cheeses.

Building the blueprint to block HIV
Profile

Building the blueprint to block HIV

Dec. 11, 2025

Wesley Sundquist will present his work on the HIV capsid and revolutionary drug, Lenacapavir, at the ASBMB Annual Meeting, March 7–10, in Maryland.

Gut microbes hijack cancer pathway in high-fat diets
Journal News

Gut microbes hijack cancer pathway in high-fat diets

Dec. 10, 2025

Researchers at the Feinstein Institutes for Medical Research found that a high-fat diet increases ammonia-producing bacteria in the gut microbiome of mice, which in turn disrupts TGF-β signaling and promotes colorectal cancer.

Mapping fentanyl’s cellular footprint
Journal News

Mapping fentanyl’s cellular footprint

Dec. 4, 2025

Using a new imaging method, researchers at State University of New York at Buffalo traced fentanyl’s effects inside brain immune cells, revealing how the drug alters lipid droplets, pointing to new paths for addiction diagnostics.

Designing life’s building blocks with AI
Profile

Designing life’s building blocks with AI

Dec. 2, 2025

Tanja Kortemme, a professor at the University of California, San Francisco, will discuss her research using computational biology to engineer proteins at the 2026 ASBMB Annual Meeting.

Cholesterol as a novel biomarker for Fragile X syndrome
Journal News

Cholesterol as a novel biomarker for Fragile X syndrome

Nov. 28, 2025

Researchers in Quebec identified lower levels of a brain cholesterol metabolite, 24-hydroxycholesterol, in patients with fragile X syndrome, a finding that could provide a simple blood-based biomarker for understanding and managing the condition.